Process enhancement. Modify. Intensify. Amplify.
Process Intensification (PI) is a comprehensive framework aimed at maximizing overall production volume across manufacturing units, manufacturing processes, or biopharmaceutical facilities. Sartorius Stedim offers scalable and versatile modular solutions, including high-throughput process development tools. These can be implemented in current and future manufacturing facilities for a variety of upstream and downstream PI scenarios. - Enables faster drug development - Improves efficiency and productivity in GMP manufacturing - Applicable to various processes regardless of the pharmaceutical ◆ International Webinar [Process Intensification Webinar Series] This webinar series provides a comprehensive guide to maximizing process intensification. It covers upstream and downstream strategies, media management, data analysis, and more. You can watch it here: ⇒ https://bit.ly/3ihwdT1
Inquire About This Product
Related Videos
basic information
Biopharmaceutical manufacturers and CDMOs are facing the challenge of improving throughput and reducing costs to maintain competitiveness, making PI seem like a natural solution. However, the reality is that implementing the level changes that many expect is difficult. Sartorius Stedim will enhance key processes to help manufacturers align current demand with future developments, allowing them to experience the current benefits of PI while building for the future.
Price range
Delivery Time
Applications/Examples of results
Key PI products across PD and the entire manufacturing process: Biostat RM and Flexsafe RM Biostat STR Generation 3 and Biobrain Automation Platform CellcaCHO Expression Platform Ambr 15 Cell Culture System Ambr 250 for perfusion-enabled processes 4Cell XtraCHO-Media System Integrated, scalable PAT Solutions With a comprehensive PD portfolio, customers can submit Investigational New Drug (IND) applications more quickly.
catalog(8)
Download All CatalogsNews about this product(5)
Company information
Sartorius Stedim, established in 2007 through the merger of the German company Sartorius, founded in 1870, and the French company Stedim, is a pioneer in "Single-Use Technology (SUT)." As a company capable of providing comprehensive technical support to the pharmaceutical and biotechnology industries, its cutting-edge technology is highly regarded worldwide in the fields of scientific instruments and biotechnology.